Skip to main content
. Author manuscript; available in PMC: 2016 Feb 5.
Published in final edited form as: J Sex Med. 2013 Apr 3;10(6):1636–1643. doi: 10.1111/jsm.12135

Table 3.

Back to baseline figures for men with functional erections at baseline (Erectile Function Domain ≥ 24)

Variable With/Without PDE5i at 24 months (%) P Not Using PDE5i at 24 months (%) P
Age
 <60(N = 81) 48 23
 ≥60(N = 51) 16 P< 0.001   4 P< 0.001
Nerve-sparing status*
 Nerves spared (N = 100) 35 16
 Unilateral resection (14) 21 P = 0.16   7 P=0.20
 Bilateral resection (N = 3)   0   0
Vascular risk factor
 No VRF (N = 54) 44 22
 ≥1 VRF (N = 78) 30 P = 0.08 12 P = 0.10

Note:

*

Fifteen subjects in this group did not have nerve-sparing status recorded.

Nine men were ≥60, 1 BTB with PDE5i.

Two men were ≥60.

BTB = back to their baseline; PDE5i = phosphodiesterase type 5 inhibitor; VRF = vascular risk factor